Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Gilead Sciences
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Individuals with chronic HCV infection
HCV RNA ≥10\^4 IU/mL at screening
HCV genotypes 2, 3, 4, 5, or 6
Cirrhosis determination; a liver biopsy may be required
Screening laboratory values within defined thresholds
Use of two contraception methods if female of childbearing potential or sexually active male
You may not be if
Pregnant or nursing female
Current or prior history of hepatic decompensation
Hepatocellular carcinoma (HCC) or other clinically significant malignancy
Infection with hepatitis B virus (HBV) or human immunodeficiency virus (HIV)
History of clinically significant illness or any other medical disorder that may interfere with the individual's treatment, assessment or compliance with the protocol
Clareo Health | Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Non-Genotype 1 HCV Infection
